Trial Profile
A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, Trivalent, Type AandB, Live, Cold-Adapted (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children With Asthma Aged 6 Years to 17 Years
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2010
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Influenza virus vaccine
- Indications Asthma; Influenza virus infections
- Focus Therapeutic Use
- Sponsors MedImmune
- 04 Dec 2006 Status change
- 13 Dec 2005 New trial record.